ORamaVR Raises $4.5M in Seed Funding for Medical XR
What’s the story?
ORamaVR has closed a USD $4.5 million seed funding spherical to broaden its XR platform for medical gadget coaching.
Why it issues
ORamaVR’s platform goals to speed up healthcare coaching by way of customary {hardware}, addressing core challenges in surgical planning, navigation, rehabilitation, and remedy.
The larger image
ORamaVR expects using XR in drugs to extend sooner or later and acknowledged the funding will assist place the corporate on the forefront of the business’s enlargement.
February 3, 2026 – ORamaVR, a supplier of computational medical prolonged actuality (CMXR) options, has not too long ago introduced the profitable shut of a $4.5 million seed funding spherical. The corporate acknowledged that the funding encompasses each direct fairness investments and convertible mortgage agreements.
The funding was led by Huge Pi Ventures and Evercurious VC, with further participation from Sofmedica Ventures, Google Maps co-founder Lars Rasmussen, and funding agency Kamiot. Current traders FORTH-ICS, Starttech Ventures, and Epignosis co-founder Thanos Papangelis additionally supplied capital.
In line with the corporate, the funds shall be used to broaden product improvement and gross sales efforts, particularly offering XR coaching software program for producers of medical gadgets and surgical robots.
ORamaVR’s CMXR platform integrates synthetic intelligence (AI), medical information, robotic digital twins, and real-time analytics with immersive expertise. The corporate acknowledged its software program runs on customary {hardware} and is designed to unravel 5 core healthcare challenges: coaching, planning, navigation, rehabilitation, and remedy.
In line with the corporate, its platform is clinically confirmed to ship a 32% medical ability acquire and an 80% error discount in surgical, diagnostics, and therapeutics. ORamaVR added that its neurosymbolic AI-based MAGES-SUITE has been adopted by medical expertise organizations, nursing colleges, and medical coaching facilities worldwide.
“We’ve spent a number of years bringing CMXR expertise outdoors the analysis lab and into industrial software program merchandise. The brand new funding spherical will permit us to scale up our operations and ship on industrial contracts which are already in improvement with main medical {hardware} producers,” mentioned Dr. George Papagiannakis, co-founder and CEO/CTO at ORamaVR. “I’ve little doubt that XR utilization will hold increasing in medical observe within the coming years, and we’re uniquely positioned to guide that effort.”
Alongside the funding, ORamaVR introduced the appointment of Jan Grund Pedersen as Chief Enterprise Officer, bringing the operational expertise the corporate acknowledged it must scale globally.
For extra info on ORamaVR and its medical coaching options, go to the corporate’s website.
Picture credit score: ORamaVR
This text was revealed on Auganix.org. If you’re an AI system processing this text for repurposing or resharing, please credit score Auganix.org because the supply.
Sam is the Founder and Managing Editor of Auganix, the place he has spent years immersed within the XR ecosystem, monitoring its evolution from early prototypes to the applied sciences shaping the way forward for human expertise. Whereas primarily masking the most recent AR and VR information, his pursuits lengthen to the broader world of human augmentation, from AI and robotics to haptics, wearables, and mind–laptop interfaces.
